Dioseve
Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden
$7MSeries A+
Role not disclosedPV
Pangaea Ventures
Activity from announced rounds
Activity in this selectionfoxconn-46a9b66b
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $55M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosed